Major heparin market players include Amphastar Pharmaceutical, Sanofi, Hepalink group, Pfizer, Leo Pharma, and Laboratorios Farmaceuticos Rovi SA.

The cardiac ablation market demand from ultrasound ablators segment will witness 14% CAGR during 2020-2026 driven by wide adoption of advanced ultrasound ablators due to its cost-effective nature, rising awareness and increasing healthcare expenditure for the improved healthcare facilities.